Aluztra Bio (Global Intellectual Property for Anagrelide)

Aluztra Bio (Global Intellectual Property for Anagrelide) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

Aluztra Bio (Global Intellectual Property for Anagrelide) General Information

Description

Global intellectual property of Anagrelide. Anagrelide is a oro-mucosal novel anti-cancer agent and potentially avoid side effects associated with the molecule when administered as an oral capsule.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • The Old Rectory, Southampton Road
  • Landford
  • Salisbury SP5 2ED
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aluztra Bio (Global Intellectual Property for Anagrelide) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aluztra Bio (Global Intellectual Property for Anagrelide)‘s full profile, request access.

Request a free trial

Aluztra Bio (Global Intellectual Property for Anagrelide) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aluztra Bio (Global Intellectual Property for Anagrelide)‘s full profile, request access.

Request a free trial